VANCOUVER, BC, April 2, 2025 /CNW/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company revolutionizing women's health, reports financial results and key business achievements for the year ended December 31, 2024. These results are presented in accordance with the International Financial Reporting Standard (IFRS) as issued by the International Accounting Standards Board. This release should be read in conjunction with the Company's audited consolidated financial statements and associated Management Discussion and Analysis ("MD&A"), available on SEDAR www.sedarplus.ca. In addition, the company announced today that Ms. Orit Berger has resigned from its Board of Directors (the "Board") for personal reasons, effective immediately.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Zero Candida Technologies Reports Full Year 2024 Financial Results and Business Highlights
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
